9-137790891-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_024757.5(EHMT1):c.2426C>T(p.Pro809Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P809R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_024757.5 missense
Scores
Clinical Significance
Conservation
Publications
- Kleefstra syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Kleefstra syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024757.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EHMT1 | NM_024757.5 | MANE Select | c.2426C>T | p.Pro809Leu | missense | Exon 16 of 27 | NP_079033.4 | ||
| EHMT1 | NM_001354263.2 | c.2405C>T | p.Pro802Leu | missense | Exon 16 of 27 | NP_001341192.1 | |||
| EHMT1 | NM_001354259.2 | c.2333C>T | p.Pro778Leu | missense | Exon 15 of 16 | NP_001341188.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EHMT1 | ENST00000460843.6 | TSL:5 MANE Select | c.2426C>T | p.Pro809Leu | missense | Exon 16 of 27 | ENSP00000417980.1 | ||
| EHMT1 | ENST00000482340.5 | TSL:5 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 5 | ENSP00000486748.1 | |||
| EHMT1 | ENST00000493484.5 | TSL:3 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 5 | ENSP00000486503.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Kleefstra syndrome 1 Pathogenic:5
The EHMT1 c.2426C>T variant is classified as PATHOGENIC (PS2, PS3, PS4, PP3) The EHMT1 c.2426C>T variant is a single nucleotide change in exon 16/27 of the EHMT1 gene, which is predicted to change the amino acid proline at position 809 in the protein to leucine. This variant has been identified as a de novo variant in this patient, although was detected in a very small proportion of reads in the mother (2 of 72, ~3%) (PS2). It has also been reported as de novo in an individual with Kleefstra syndrome in the literature, along with another unrelated Kleefstra syndrome case (PMID: 28057753; PS4). This variant is absent from population databases (PM2). Functional studies have demonstrated the variant leads to protein misfolding and aberrant target recognition via disrupted histone mark binding (PS3). Computational predictions support a deleterious effect on the gene or gene product (PP3). This variant has been reported in dbSNP (rs587780332) and has been reported as likely pathogenic by other diagnostic laboratories (ClinVar Variation ID: 128978), and damaging for Kleefstra syndrome in HGMD (CM172582).
This variant is classified as Pathogenic. Evidence in support of pathogenic classification: Variant is absent from gnomAD (v2, v3 and v4); This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been classified as likely pathogenic and pathogenic by clinical laboratories (ClinVar, DECIPHER), and reported in the literature in individuals with Kleefstra syndrome (PMIDs: 39696517, 28057753); Missense variant predicted to be damaging by in silico tool(s) or highly conserved with a major amino acid change. Additional information: Variant is predicted to result in a missense amino acid change from Pro to Leu; This variant is heterozygous; This gene is associated with autosomal dominant disease; Loss of function is a known mechanism of disease in this gene and is associated with Kleefstra syndrome 1 (MIM#610253); Inheritance information for this variant is not currently available in this individual.
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects EHMT1 function (PMID: 28057753). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 128978). This missense change has been observed in individual(s) with clinical features of Kleefstra syndrome (PMID: 28057753, 29276005, 31785789, 33767182). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 809 of the EHMT1 protein (p.Pro809Leu).
c.2426C>T (exon16, NM_024757), resulting in the amino acid change p.P809L, a missense mutation. The mutation was initially determined to be a pathogenic mutation (Pathogenic) PS2+PS4+PM2+PP3 according to the ACMG guidelines: PS2: After family validation analysis, there is no mutation at this locus in the subject's father and no mutation at this locus in the subject's mother, and this variant is a spontaneous mutation; PS4: cases of this locus (Kleefstra syndrome) have been reported in the literature database, with the variant labeled DM (pathogenic mutation), ClinVar The pathogenicity analysis of this locus in the ClinVar database is Conflicting interpretations of pathogenicity,- ; PM2: the frequency in the normal population database is -, a low-frequency variant; PP3: Bioinformatics protein function comprehensive prediction software REVEL predicted the results as harmful, SIFT, PolyPhen_2, MutationTaster , GERP+ predicted the results as harmful, harmful, harmful, harmful, harmful, respectively;
not provided Pathogenic:2Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at